Giulio Donati

1.2k total citations
17 papers, 885 citations indexed

About

Giulio Donati is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Giulio Donati has authored 17 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Giulio Donati's work include Cancer-related Molecular Pathways (13 papers), RNA modifications and cancer (7 papers) and Ubiquitin and proteasome pathways (5 papers). Giulio Donati is often cited by papers focused on Cancer-related Molecular Pathways (13 papers), RNA modifications and cancer (7 papers) and Ubiquitin and proteasome pathways (5 papers). Giulio Donati collaborates with scholars based in Italy, Spain and United States. Giulio Donati's co-authors include Massimo Derenzini, Lorenzo Montanaro, George Thomas, Carol A. Mercer, Suresh Peddigari, Davide Treré, Siniša Volarević, Bruno Amati, Manuela Vici and Elisa Brighenti and has published in prestigious journals such as Development, Cancer Research and Oncogene.

In The Last Decade

Giulio Donati

17 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulio Donati Italy 11 707 366 120 82 52 17 885
Sophia X. Pfister United Kingdom 9 831 1.2× 216 0.6× 139 1.2× 93 1.1× 57 1.1× 11 959
Colin J. Daniel United States 14 704 1.0× 291 0.8× 144 1.2× 56 0.7× 75 1.4× 21 815
Amanda R. Wasylishen United States 15 465 0.7× 257 0.7× 179 1.5× 68 0.8× 33 0.6× 25 643
Nikolina Vlatković United Kingdom 18 626 0.9× 388 1.1× 169 1.4× 134 1.6× 55 1.1× 26 828
Tiziana Tonini United States 11 431 0.6× 229 0.6× 143 1.2× 53 0.6× 58 1.1× 15 646
Deepti B. Ramnarain United States 10 513 0.7× 190 0.5× 135 1.1× 77 0.9× 75 1.4× 10 666
Edith A. Leonhardt United States 8 587 0.8× 253 0.7× 172 1.4× 64 0.8× 59 1.1× 11 764
Dragana Kopanja United States 16 624 0.9× 230 0.6× 136 1.1× 48 0.6× 32 0.6× 20 739
Jack Wu United States 14 625 0.9× 251 0.7× 196 1.6× 46 0.6× 28 0.5× 18 778
Miaw-Sheue Tsai United States 21 996 1.4× 339 0.9× 147 1.2× 37 0.5× 32 0.6× 31 1.1k

Countries citing papers authored by Giulio Donati

Since Specialization
Citations

This map shows the geographic impact of Giulio Donati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulio Donati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulio Donati more than expected).

Fields of papers citing papers by Giulio Donati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulio Donati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulio Donati. The network helps show where Giulio Donati may publish in the future.

Co-authorship network of co-authors of Giulio Donati

This figure shows the co-authorship network connecting the top 25 collaborators of Giulio Donati. A scholar is included among the top collaborators of Giulio Donati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulio Donati. Giulio Donati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Donati, Giulio, Paola Nicoli, Alessandro Verrecchia, et al.. (2023). Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC ‐driven lymphoma. EMBO Molecular Medicine. 15(6). e16910–e16910. 10 indexed citations
2.
Donati, Giulio & Bruno Amati. (2022). MYC and therapy resistance in cancer: risks and opportunities. Molecular Oncology. 16(21). 3828–3854. 50 indexed citations
3.
Donati, Giulio, Micol Ravà, M. Filipuzzi, et al.. (2021). Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma. Molecular Oncology. 16(5). 1132–1152. 10 indexed citations
4.
Göker, Funda, et al.. (2020). Treatment of BRONJ with ozone/oxygen therapy and debridement with piezoelectric surgery. Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano). 8 indexed citations
5.
Ravà, Micol, Aleco D’Andrea, Paola Nicoli, et al.. (2018). Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC / BCL2 double-hit B cell lymphoma. Science Translational Medicine. 10(426). 41 indexed citations
6.
Bursać, Slađana, Maja Cokarić Brdovčak, Giulio Donati, & Siniša Volarević. (2013). Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(6). 817–830. 114 indexed citations
7.
Donati, Giulio, Suresh Peddigari, Carol A. Mercer, & George Thomas. (2013). 5S Ribosomal RNA Is an Essential Component of a Nascent Ribosomal Precursor Complex that Regulates the Hdm2-p53 Checkpoint. Cell Reports. 4(1). 87–98. 200 indexed citations
8.
Donati, Giulio & George Thomas. (2012). Apoptosis in pluripotent stem cells: RPL11 strikes again. Cell Cycle. 11(5). 840–840. 3 indexed citations
9.
Donati, Giulio, Lorenzo Montanaro, & Massimo Derenzini. (2012). Ribosome Biogenesis and Control of Cell Proliferation: p53 Is Not Alone. Cancer Research. 72(7). 1602–1607. 137 indexed citations
10.
Donati, Giulio, Serena Bertoni, Elisa Brighenti, et al.. (2011). The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. Oncogene. 30(29). 3274–3288. 78 indexed citations
11.
Donati, Giulio, Elisa Brighenti, Manuela Vici, et al.. (2011). Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. Journal of Cell Science. 124(17). 3017–3028. 69 indexed citations
12.
Donati, Giulio, Elisa Brighenti, Manuela Vici, et al.. (2011). Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. Development. 138(18). e1808–e1808. 1 indexed citations
13.
Treré, Davide, Elisa Brighenti, Giulio Donati, et al.. (2009). High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. Annals of Oncology. 20(11). 1818–1823. 73 indexed citations
14.
Derenzini, Massimo, Elisa Brighenti, Giulio Donati, et al.. (2009). The p53‐mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein. The Journal of Pathology. 219(3). 373–382. 14 indexed citations
15.
Derenzini, Massimo, Giulio Donati, Giuliano Mazzini, et al.. (2008). Loss of Retinoblastoma Tumor Suppressor Protein Makes Human Breast Cancer Cells More Sensitive to Antimetabolite Exposure. Clinical Cancer Research. 14(7). 2199–2209. 35 indexed citations
16.
Montanaro, Lorenzo, Giuliano Mazzini, Stefania Barbieri, et al.. (2007). Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein‐ and p53‐deficient and proficient human osteosarcoma cell lines. Cell Proliferation. 40(4). 532–549. 39 indexed citations
17.
Montanaro, Lorenzo, Manuela Vici, Giulio Donati, et al.. (2007). Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer.. PubMed. 22(7). 769–75. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophia X. Pfister Breakdown of academic impact, for papers by Colin J. Daniel Breakdown of academic impact, for papers by Amanda R. Wasylishen Breakdown of academic impact, for papers by Nikolina Vlatković Breakdown of academic impact, for papers by Tiziana Tonini Breakdown of academic impact, for papers by Deepti B. Ramnarain Breakdown of academic impact, for papers by Edith A. Leonhardt Breakdown of academic impact, for papers by Dragana Kopanja Breakdown of academic impact, for papers by Jack Wu Breakdown of academic impact, for papers by Miaw-Sheue Tsai
Rankless by CCL
2026